Skip to main content

Litfulo News

A New Treatment Option for a Form of Sudden Hair Loss

THURSDAY, Aug. 17, 2023 – A new type of medication, JAK inhibitors, can effectively treat moderate to severe alopecia areata, a hair loss condition that has been historically hard to treat. A study...

FDA Approves Litfulo (ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata

NEW YORK--(BUSINESS WIRE) June 23, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Litfulo™ (ritlecitinib), a once-daily oral treatment, f...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Alopecia

Litfulo patient information at Drugs.com